$293.69
1.70.58%
Last update: 10:10 AM
15 minutes delayed
Molina Healthcare
MOHNYSE
Molina Healthcare (NYSE:MOH) Stock, Analyst Ratings, Price Targets, Predictions
Molina Healthcare Inc has a consensus price target of $381.08, established from looking at the 70 latest analyst ratings. The last 3 analyst ratings were released from JP Morgan, Baird, and TD Cowen on May 30, 2024, May 30, 2024, and April 30, 2024. With an average price target of $412.33 between JP Morgan, Baird, and TD Cowen, there's an implied 40.40% upside for Molina Healthcare Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
JP Morgan
Baird
TD Cowen
Wells Fargo
Stephens & Co.
1calculated from analyst ratings
Analyst Ratings for Molina Healthcare
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/30/2024 | Buy Now | 43.01% | JP Morgan | Lisa Gill | $435 → $420 | Maintains | Overweight | Get Alert |
| 05/30/2024 | Buy Now | 37.9% | Baird | Michael Ha | → $405 | Initiates | → Outperform | Get Alert |
| 04/30/2024 | Buy Now | 40.28% | TD Cowen | Gary Taylor | $453 → $412 | Maintains | Buy | Get Alert |
| 04/29/2024 | Buy Now | 27.68% | Wells Fargo | Stephen Baxter | $410 → $375 | Maintains | Equal-Weight | Get Alert |
| 04/25/2024 | Buy Now | 32.79% | Stephens & Co. | Scott Fidel | — | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 04/25/2024 | Buy Now | 46.41% | Barclays | Andrew Mok | $437 → $430 | Maintains | Equal-Weight | Get Alert |
| 04/15/2024 | Buy Now | 39.6% | Wells Fargo | Stephen Baxter | $440 → $410 | Maintains | Equal-Weight | Get Alert |
| 04/04/2024 | Buy Now | 38.24% | Cantor Fitzgerald | Sarah James | → $406 | Reiterates | Overweight → Overweight | Get Alert |
| 04/01/2024 | Buy Now | 49.47% | B of A Securities | Kevin Fischbeck | → $439 | Downgrade | Neutral → Underperform | Get Alert |
| 03/28/2024 | Buy Now | 49.47% | B of A Securities | Kevin Fischbeck | → $439 | Downgrade | Neutral → Underperform | Get Alert |
| 03/20/2024 | Buy Now | 49.82% | Wells Fargo | Stephen Baxter | $420 → $440 | Maintains | Equal-Weight | Get Alert |
| 03/06/2024 | Buy Now | 48.79% | Barclays | Andrew Mok | → $437 | Initiates | → Equal-Weight | Get Alert |
| 02/20/2024 | Buy Now | 56.63% | Truist Securities | David Macdonald | $435 → $460 | Maintains | Buy | Get Alert |
| 02/15/2024 | Buy Now | 43.01% | Wells Fargo | Stephen Baxter | $367 → $420 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 02/09/2024 | Buy Now | 38.24% | Cantor Fitzgerald | Sarah James | $374 → $406 | Maintains | Overweight | Get Alert |
| 12/21/2023 | Buy Now | 29.39% | UBS | Kevin Caliendo | $350 → $380 | Maintains | Neutral | Get Alert |
| 11/21/2023 | Buy Now | 27.34% | Cantor Fitzgerald | Sarah James | → $374 | Reiterates | Overweight → Overweight | Get Alert |
| 11/17/2023 | Buy Now | 33.47% | JP Morgan | Calvin Sternick | $367 → $392 | Maintains | Overweight | Get Alert |
| 10/03/2023 | Buy Now | 19.17% | Stephens & Co. | Scott Fidel | → $350 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 09/14/2023 | Buy Now | 22.24% | Cantor Fitzgerald | Sarah James | → $359 | Reiterates | Overweight → Overweight | Get Alert |
| 07/14/2023 | Buy Now | 24.28% | Morgan Stanley | Ricky Goldwasser | $365 → $365 | Reiterates | Overweight → Overweight | Get Alert |
| 07/07/2023 | Buy Now | 16.11% | JP Morgan | Calvin Sternick | $348 → $341 | Maintains | Overweight | Get Alert |
| 06/20/2023 | Buy Now | 24.28% | Truist Securities | David Macdonald | $380 → $365 | Maintains | Buy | Get Alert |
| 06/20/2023 | Buy Now | 5.55% | UBS | Kevin Caliendo | → $310 | Initiates | → Neutral | Get Alert |
| 05/08/2023 | Buy Now | 14.06% | Deutsche Bank | George Hill | $365 → $335 | Maintains | Hold | Get Alert |
| 05/03/2023 | Buy Now | 18.83% | TD Cowen | Gary Taylor | $380 → $349 | Maintains | Outperform | Get Alert |
| 05/01/2023 | Buy Now | 24.28% | Deutsche Bank | George Hill | $356 → $365 | Maintains | Hold | Get Alert |
| 04/28/2023 | Buy Now | 19.17% | Credit Suisse | Jonathan Yong | $347 → $350 | Maintains | Outperform | Get Alert |
| 04/28/2023 | Buy Now | -1.26% | Wells Fargo | Stephen Baxter | $282 → $290 | Maintains | Underweight | Get Alert |
| 04/27/2023 | Buy Now | 19.17% | Stephens & Co. | Scott Fidel | → $350 | Reiterates | → Equal-Weight | Get Alert |
| 04/21/2023 | Buy Now | 20.53% | Cantor Fitzgerald | Sarah James | → $354 | Initiates | → Overweight | Get Alert |
| 03/21/2023 | Buy Now | -3.98% | Wells Fargo | Stephen Baxter | $307 → $282 | Maintains | Underweight | Get Alert |
| 02/23/2023 | Buy Now | 18.49% | JP Morgan | Calvin Sternick | $360 → $348 | Maintains | Overweight | Get Alert |
| 02/17/2023 | Buy Now | 4.53% | Wells Fargo | Stephen Baxter | $340 → $307 | Maintains | Underweight | Get Alert |
| 02/10/2023 | Buy Now | 29.39% | Truist Securities | David Macdonald | $400 → $380 | Maintains | Buy | Get Alert |
| 02/10/2023 | Buy Now | 18.15% | Credit Suisse | Jonathan Yong | $395 → $347 | Maintains | Outperform | Get Alert |
| 02/09/2023 | Buy Now | 27.68% | Stephens & Co. | Scott Fidel | → $375 | Maintains | Equal-Weight | Get Alert |
| 01/04/2023 | Buy Now | 27.68% | Barclays | Steve Valiquette | $400 → $375 | Maintains | Overweight | Get Alert |
| 01/03/2023 | Buy Now | 15.77% | Wells Fargo | Stephen Baxter | $345 → $340 | Maintains | Underweight | Get Alert |
| 12/13/2022 | Buy Now | 32.11% | B of A Securities | Kevin Fischbeck | → $388 | Upgrade | Underperform → Neutral | Get Alert |
| 11/01/2022 | Buy Now | 20.87% | Deutsche Bank | George Hill | $315 → $355 | Maintains | Hold | Get Alert |
| 10/28/2022 | Buy Now | 36.2% | Barclays | Steven Valiquette | $380 → $400 | Maintains | Overweight | Get Alert |
| 10/28/2022 | Buy Now | 43.01% | Truist Securities | David Macdonald | $390 → $420 | Maintains | Buy | Get Alert |
| 10/27/2022 | Buy Now | 39.6% | Credit Suisse | A.J. Rice | $350 → $410 | Maintains | Outperform | Get Alert |
| 10/03/2022 | Buy Now | 22.58% | JP Morgan | Calvin Sternick | → $360 | Initiates | → Overweight | Get Alert |
| 08/26/2022 | Buy Now | 17.47% | Wells Fargo | Stephen Baxter | $307 → $345 | Maintains | Underweight | Get Alert |
| 07/29/2022 | Buy Now | 24.62% | Mizuho | Ann Hynes | $345 → $366 | Maintains | Buy | Get Alert |
| 07/29/2022 | Buy Now | 29.39% | Barclays | Steve Valiquette | $340 → $380 | Maintains | Overweight | Get Alert |
| 06/17/2022 | Buy Now | 5.55% | Loop Capital | Joseph France | → $310 | Initiates | → Hold | Get Alert |
| 05/26/2022 | Buy Now | 14.06% | B of A Securities | Kevin Fischbeck | $355 → $335 | Downgrade | Buy → Underperform | Get Alert |
| 05/25/2022 | Buy Now | 2.49% | Wells Fargo | Stephen Baxter | $308 → $301 | Maintains | Underweight | Get Alert |
| 05/02/2022 | Buy Now | 5.89% | Deutsche Bank | George Hill | $308 → $311 | Maintains | Hold | Get Alert |
| 02/22/2022 | Buy Now | 24.28% | Morgan Stanley | Ricky Goldwasser | $397 → $365 | Maintains | Overweight | Get Alert |
| 02/14/2022 | Buy Now | 29.39% | BMO Capital | Matt Borsch | $365 → $380 | Maintains | Outperform | Get Alert |
| 02/11/2022 | Buy Now | 17.47% | Mizuho | Ann Hynes | $330 → $345 | Maintains | Buy | Get Alert |
| 12/14/2021 | Buy Now | 14.06% | Goldman Sachs | Nathan Rich | — | Initiates | → Buy | Get Alert |
| 11/02/2021 | Buy Now | -4.32% | Wells Fargo | Stephen Baxter | — | Maintains | Underweight | Get Alert |
| 10/29/2021 | Buy Now | 35.17% | Morgan Stanley | — | — | Maintains | Overweight | Get Alert |
| 10/29/2021 | Buy Now | 2.15% | Stephens & Co. | Scott Fidel | — | Maintains | Equal-Weight | Get Alert |
| 10/29/2021 | Buy Now | 12.36% | Credit Suisse | Jonathan Yong | — | Maintains | Outperform | Get Alert |
| 10/29/2021 | Buy Now | 15.77% | Barclays | Steve Valiquette | — | Maintains | Overweight | Get Alert |
| 09/20/2021 | Buy Now | 8.28% | Credit Suisse | — | — | Maintains | Outperform | Get Alert |
| 09/20/2021 | Buy Now | 12.36% | Truist Securities | David Macdonald | — | Maintains | Buy | Get Alert |
| 09/20/2021 | Buy Now | -4.66% | Stephens & Co. | Scott Fidel | — | Maintains | Equal-Weight | Get Alert |
| 09/20/2021 | Buy Now | 7.59% | Morgan Stanley | Ricky Goldwasser | — | Maintains | Overweight | Get Alert |
| 09/20/2021 | Buy Now | 3.85% | Mizuho | Ann Hynes | — | Maintains | Buy | Get Alert |
| 08/31/2021 | Buy Now | 0.78% | Morgan Stanley | Craig Hettenbach | — | Maintains | Overweight | Get Alert |
| 08/03/2021 | Buy Now | -12.83% | Wells Fargo | Stephen Baxter | — | Maintains | Underweight | Get Alert |
| 07/30/2021 | Buy Now | 7.25% | BMO Capital | Matt Borsch | — | Maintains | Outperform | Get Alert |
| 07/30/2021 | Buy Now | -3.3% | Mizuho | Ann Hynes | — | Maintains | Buy | Get Alert |
FAQ
What is the target price for Molina Healthcare (MOH) stock?
The latest price target for Molina Healthcare (NYSE:MOH) was reported by JP Morgan on May 30, 2024. The analyst firm set a price target for $420.00 expecting MOH to rise to within 12 months (a possible 43.01% upside). 22 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Molina Healthcare (MOH)?
The latest analyst rating for Molina Healthcare (NYSE:MOH) was provided by JP Morgan, and Molina Healthcare maintained their overweight rating.
When was the last upgrade for Molina Healthcare (MOH)?
The last upgrade for Molina Healthcare Inc happened on February 15, 2024 when Wells Fargo raised their price target to $420. Wells Fargo previously had an underweight for Molina Healthcare Inc.
When was the last downgrade for Molina Healthcare (MOH)?
The last downgrade for Molina Healthcare Inc happened on April 1, 2024 when B of A Securities changed their price target from N/A to $439 for Molina Healthcare Inc.
When is the next analyst rating going to be posted or updated for Molina Healthcare (MOH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Molina Healthcare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Molina Healthcare was filed on May 30, 2024 so you should expect the next rating to be made available sometime around May 30, 2025.
Is the Analyst Rating Molina Healthcare (MOH) correct?
While ratings are subjective and will change, the latest Molina Healthcare (MOH) rating was a maintained with a price target of $435.00 to $420.00. The current price Molina Healthcare (MOH) is trading at is $293.70, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.